Early detection of relapse and early therapeutic intervention: The benefits of Devyser NGS method for chimerism analysis
A better patient care is the final objective for Dr. Helena Devos and the team at Sint Jan’s...
Browse our upcoming physical and virtual events to find a workshop, webinar, tradeshow or networking session you might want to attend.
Tradeshow I June 3-7, 2023
American Transplant Congress (ATC)
California, United States of America
Visit us at booth #937 during the American Transplant Congress 2023 in San Diego and learn more from our experts about Devyser Accept cfDNA.
Tradeshow I June 10-13, 2023
The European Human Genetics Conference (ESHG)
Glasgow, United Kingdom
Join us at ESHG 2023 in Glasgow! Meet our team at booth #470 and join our corporate satellite on "Genetic testing for everyone, navigating IVDR and NGS" featuring Professor Milan Macek Jr. and Silvia Borras.
🕕 Sunday, June 11, 18:30-20:00
📍 Alsh 1, level 0
Tradeshow I June 17-20, 2023
The Transplantation Society of Australia and New Zealand (TSANZ)
Brisbane, Australia
We are excited to be part of the Transplantation Society of Australia and New Zealand 2023 with our partner Abacus. Come and meet our team or book a meeting with us.
Tradeshow I June 17-21, 2023
International Society of Blood Transfusion Congress (ISBT)
Gothenburg, Sweden
Join us at the ISBT Congress 2023. We are excited to meet key experts and discuss scientific and clinical topics with peers from the field. We look forward to learning from and contributing to the conversation at ISBT2023.
Browse our past webinars that are designed to provide valuable insights and knowledge on a wide range of topics
Webinar I February 16, 2023
Post-transplant monitoring: The future of chimerism testing
Join our webinar featuring Dr. Helena Devos, MD, Clinical Biologist and Dr. Freidel Nollet, PhD, Molecular Biologist at AZ Sint-Jan in Bruges, Belgium. Where we will talk about the implementation of an NGS solution for chimerism testing and the clinical perspectives.
Webinar I April 12, 2023
NGS for thalassemia genetic testing – insights from a customer implementation journey
Watch our webinar featuring Dr. Thessalia Papasavva at the Cyprus Institute of Neurology and Genetics is performing genetic testing for thalassemia in Cyprus, both for diagnostics and as part of the national screening programs.
News | May 8, 2023
Devyser winner of Swecare Export Awards 2023News | April 24, 2023
Devyser enters agreement with Thermo Fisher Scientific for commercialization of Devyser’s post-transplant NGS productsNews | March 1, 2023
Devyser launches first IVDR-certified productA better patient care is the final objective for Dr. Helena Devos and the team at Sint Jan’s...
Read More
As a lab manager, you know the importance of streamlining workflows to maximize productivity and...
Read More
With new more sensitive diagnostics, rejection of a transplanted kidney can be detected earlier,...
Read More
Hematopoietic stem cell transplantation (HSCT) is the only curative treatment for patients with...
Read More